<< Back To Home

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar

Saturday, 19th of January 2019 Print

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar

Razafindratsimandresy R, Mach O, Heraud JM, Bernardson B, Weldon WC, Oberste MS, Sutter RW.

Heliyon. 2018 Mar 7;4(3):e00563.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857717/

24760492